Atkins GJ - Search Results

1

Alphaviruses and their derived vectors as anti-tumor agents.

Atkins GJ, Smyth JW, Fleeton MN, Galbraith SE, Sheahan BJ. Atkins GJ, et al. Curr Cancer Drug Targets. 2004 Nov;4(7):597-607. doi: 10.2174/1568009043332754. Curr Cancer Drug Targets. 2004. PMID: 15578917 Review.

2

Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.

Callagy SJ, Kelly BJ, Fleeton MN, Sheahan BJ, Galbraith SE, Atkins GJ. Callagy SJ, et al. Among authors: atkins gj. Vaccine. 2007 Oct 23;25(43):7481-90. doi: 10.1016/j.vaccine.2007.08.049. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17905485

3

Potential of alphavirus vectors in the treatment of advanced solid tumors.

Kelly BJ, Fleeton MN, Atkins GJ. Kelly BJ, et al. Among authors: atkins gj. Recent Pat Anticancer Drug Discov. 2007 Jun;2(2):159-66. doi: 10.2174/157489207780832432. Recent Pat Anticancer Drug Discov. 2007. PMID: 18221060 Review.

4

Therapeutic and prophylactic applications of alphavirus vectors.

Atkins GJ, Fleeton MN, Sheahan BJ. Atkins GJ, et al. Expert Rev Mol Med. 2008 Nov 11;10:e33. doi: 10.1017/S1462399408000859. Expert Rev Mol Med. 2008. PMID: 19000329 Review.

5

Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector.

Murphy AM, Sheahan BJ, Atkins GJ. Murphy AM, et al. Among authors: atkins gj. Int J Cancer. 2001 Nov;94(4):572-8. doi: 10.1002/ijc.1495. Int J Cancer. 2001. PMID: 11745446

6

Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.

Smyth JW, Fleeton MN, Sheahan BJ, Atkins GJ. Smyth JW, et al. Among authors: atkins gj. Gene Ther. 2005 Jan;12(2):147-59. doi: 10.1038/sj.gt.3302390. Gene Ther. 2005. PMID: 15372069

7

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

Atkins GJ, Sheahan BJ, Liljeström P. Atkins GJ, et al. J Gen Virol. 1999 Sep;80 ( Pt 9):2287-2297. doi: 10.1099/0022-1317-80-9-2287. J Gen Virol. 1999. PMID: 10501479 Review. No abstract available.

8

Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection.

Keogh B, Sheahan BJ, Atkins GJ, Mills KH. Keogh B, et al. Among authors: atkins gj. Vet Immunol Immunopathol. 2003 Aug 15;94(3-4):185-90. doi: 10.1016/s0165-2427(03)00082-5. Vet Immunol Immunopathol. 2003. PMID: 12909414

9

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

Jerusalmi A, Morris-Downes MM, Sheahan BJ, Atkins GJ. Jerusalmi A, et al. Among authors: atkins gj. Mol Ther. 2003 Dec;8(6):886-94. doi: 10.1016/j.ymthe.2003.09.010. Mol Ther. 2003. PMID: 14664790 Free article.

10

Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.

Galbraith SE, Sheahan BJ, Atkins GJ. Galbraith SE, et al. Among authors: atkins gj. J Gen Virol. 2006 Apr;87(Pt 4):937-947. doi: 10.1099/vir.0.81406-0. J Gen Virol. 2006. PMID: 16528043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters